Frailty increased during the first year after the initiation of dialysis in patients with end-stage kidney disease. Pre-dialysis frailty was associated with an increased risk for hospitalisation, and ...
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA–Expressing Platinum-Resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback